Haemophilus influenzae type b (Hib): Infection, Symptoms, and Vaccination
Haemophilus influenzae type b (Hib) is a bacterial infection that was once one of the most feared childhood illnesses in the world. Routine vaccination has dramatically reduced its burden — but it has not eliminated it. Where vaccine coverage is incomplete, Hib remains capable of causing fast-moving, life-threatening disease.
At a glance: Despite its name, Hib has nothing to do with influenza. It is a bacterium that can cause bacterial meningitis, epiglottitis, and sepsis — primarily in young children. Vaccination has made it rare, but not gone.
Key Points
- Hib is a bacterial infection, not related to the influenza virus
- It can cause meningitis, epiglottitis, pneumonia, and sepsis
- Before vaccination, it was the leading cause of bacterial meningitis in children under five
- Vaccination has made severe Hib disease much rarer in countries with strong immunisation programs
- Cases still occur, particularly where vaccine coverage is incomplete or in people with immune deficiencies
Background
Haemophilus influenzae is a group of bacteria first identified during the 1890 influenza pandemic. At the time, scientists mistakenly thought the bacterium caused influenza — hence the name. The influenza virus was not identified until the 1930s.
There are several types of Haemophilus influenzae, distinguished by their surface capsules (types a through f) or by lacking a capsule entirely (non-typeable strains). Type b (Hib) was historically the most dangerous, responsible for the large majority of serious invasive disease before vaccines were introduced.
Before routine Hib vaccination became widespread in the early 1990s:
- Hib was the most common cause of bacterial meningitis in children under five in many countries
- Approximately 1 in 200 children under five in the United States developed invasive Hib disease before age five
- Thousands of children died each year; many more were left with permanent hearing loss or brain damage
- Epiglottitis — a rapidly progressive, life-threatening swelling of the airway — was predominantly a paediatric Hib disease
Vaccination changed this picture dramatically. In countries with high coverage, invasive Hib disease fell by more than 95%.
How Hib Spreads
Hib lives in the nose and throat of infected people and some asymptomatic carriers. It spreads primarily through:
- Respiratory droplets — coughing, sneezing, or close contact
- Direct contact with respiratory secretions
Most people who carry Hib in their nasopharynx never become seriously ill. Invasive disease occurs when the bacterium crosses from the respiratory tract into the bloodstream or surrounding tissues, triggering infection in the brain, lungs, blood, joints, or other sites.
Young children are particularly vulnerable because their immune systems have not yet developed the antibodies needed to contain Hib before it spreads.
Symptoms and Complications
Hib can cause several distinct clinical syndromes. The presentation depends on which part of the body is infected.
| Condition | What it can cause |
|---|---|
| Meningitis | Fever, lethargy, neck stiffness, headache, vomiting, photophobia; neurological complications including hearing loss and brain damage |
| Epiglottitis | Severe throat swelling, high fever, drooling, difficulty swallowing, stridor; emergency airway risk requiring urgent intervention |
| Pneumonia | Cough, fever, rapid breathing, chest pain; may require hospitalisation |
| Sepsis | Rapid deterioration, high fever or hypothermia, poor perfusion, shock; can be fatal within hours |
| Septic arthritis | Joint swelling, pain, reduced movement; primarily large joints in young children |
| Cellulitis | Skin infection, typically on the face or neck in young children; may indicate bloodstream spread |
Hib meningitis and epiglottitis are the presentations most likely to be immediately life-threatening.
Diagnosis and Treatment
Diagnosis is based on clinical suspicion and confirmed with laboratory testing:
- Blood cultures are the primary diagnostic tool for invasive disease
- Cerebrospinal fluid (CSF) culture and analysis for suspected meningitis
- Imaging and other tests depending on the clinical picture
Hib infection is a medical emergency. Suspected cases require:
- Urgent hospital admission
- Intravenous antibiotics — third-generation cephalosporins (e.g., ceftriaxone) are standard first-line treatment
- Supportive intensive care where required, including airway management for epiglottitis
- Corticosteroids are sometimes used alongside antibiotics in meningitis to reduce inflammation and the risk of complications such as hearing loss
Early treatment significantly improves outcomes. Delays increase the risk of permanent complications and death.
Risks and Prognosis
Without treatment, invasive Hib disease carries a high risk of death or serious permanent injury. Even with treatment:
- Bacterial meningitis causes permanent hearing loss in approximately 15–20% of survivors and other neurological complications in a significant proportion
- Epiglottitis can cause fatal airway obstruction if not managed immediately
- Sepsis carries a substantial mortality risk, particularly if there is delayed recognition
Long-term effects after invasive Hib disease can include cognitive difficulties, developmental delays, and communication problems, depending on the extent of any neurological involvement.
Vaccination substantially reduces all of these risks by preventing the infection from occurring in the first place.
Vaccination
The Hib conjugate vaccine, introduced into routine childhood schedules in the early 1990s, is one of the most successful vaccines ever developed.
Key points about Hib vaccination:
- Hib vaccine is included in routine childhood immunisation schedules in most high-income countries and an increasing number of lower-income countries
- In Australia, Hib vaccine is given as part of combination vaccines at 2, 4, and 6 months, with a booster at 12–18 months, under the National Immunisation Program
- Combination vaccines (such as those also covering diphtheria, tetanus, pertussis, hepatitis B, and polio) are commonly used to reduce the number of injections
Catch-up vaccination is recommended for children who have missed scheduled doses — the schedule depends on age and number of prior doses. Adults without a spleen, or with certain immune conditions, should discuss Hib vaccination with their clinician.
Vaccination does not only protect the individual — high coverage reduces circulation of the bacterium, protecting those who cannot be vaccinated.
Frequently Asked Questions
Is Hib the same as influenza? No. Haemophilus influenzae type b is a bacterium. The influenza virus is a completely separate pathogen. The name is a historical error from the pre-virology era. Hib infection does not cause the flu.
How serious is Hib infection? Invasive Hib disease is a medical emergency. Meningitis, epiglottitis, and sepsis can progress to death or permanent disability within hours. Even with treatment, a significant proportion of survivors have lasting complications.
Who is most at risk? Children under five are at highest risk, particularly infants under twelve months who have not yet completed the primary vaccination course. People without a functioning spleen, those with immune deficiencies, and unvaccinated individuals of any age also carry elevated risk.
Do adults need Hib vaccination? Most adults who completed childhood vaccination do not need Hib vaccine. Exceptions include people without a spleen (asplenia), those with certain immune conditions including HIV, and adults who were never vaccinated. Discuss with a clinician if you are unsure of your vaccination history.
What happens if a child misses a Hib dose? Missed doses should be caught up as soon as possible. The number of doses required depends on the child’s age at the time of catch-up. An immunisation provider can advise on the appropriate schedule. Partial vaccination still provides some protection, but completing the course is important.
Can Hib still happen in vaccinated populations? Yes, though rarely. Occasional vaccine failure occurs. More commonly, cases arise in under-vaccinated individuals or communities where coverage has fallen. Immunocompromised people may also be at risk despite vaccination. Pockets of under-vaccination allow Hib to continue circulating, creating ongoing risk.
Further Reading
- CDC: Hib Disease and Vaccination
- WHO: Haemophilus influenzae type b (Hib)
- Australian Immunisation Handbook — Haemophilus influenzae type b